L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
about
The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression.Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock
P2860
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
@en
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
@nl
type
label
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
@en
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
@nl
prefLabel
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
@en
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
@nl
P2093
P2860
P1433
P1476
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
@en
P2093
Amit Gaggar
C Roger White
Edlue M Tabengwa
G M Anantharamaiah
Himanshu Gupta
Mayakonda N Palgunachari
Oleg F Sharifov
P2860
P2888
P304
P356
10.1007/S10753-014-9864-7
P577
2014-10-01T00:00:00Z